Evidence map›Paper›PMID 42053295›Full record

ArticleJournal of virology2026

Pseudovirus-mediated proximity labeling identifies candidate host cell membrane proteins involved in viral attachment.

Norihiro Kotani, Kensuke Iwasa, Tomoko Amimoto, Chikara Yamashita, Kumiko Komatsu, Yutaka Narimichi, Yoshiki Wakabayashi, Yuuki Kurebayashi, Yutaka Horiuchi, Leona Kashimata and 10 more

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Norihiro KotaniDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.ORCID 0000-0003-3739-6478
Kensuke IwasaDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Tomoko AmimotoNatural Science Center for Basic Research and Development, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.ORCID 0000-0003-3614-1887
Chikara YamashitaDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Kumiko KomatsuBiomedical Research Center, Saitama Medical University, Iruma-gun, Saitama, Japan.
Yutaka NarimichiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Yoshiki WakabayashiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Yuuki KurebayashiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Yutaka HoriuchiDepartment of Microbiology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Leona KashimataDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Ryoko SasakiDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Megumi KumagaiDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Nan Yagishita-KyoDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Takeo AwajiDepartment of Pharmacology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Takashi MurakamiDepartment of Microbiology, Saitama Medical University, Iruma-gun, Saitama, Japan.
Yosuke MizunoBiomedical Research Center, Saitama Medical University, Iruma-gun, Saitama, Japan.
Miyako NakanoGraduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.
Tadanobu TakahashiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Hideyuki TakeuchiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Koichi HonkeDepartment of Biochemistry, Kochi University Medical School, Nankoku, Kochi, Japan.

Funding

Japan Society for the Promotion of Science JP21K06562Takeda Science Foundation
6 · The paper itself

Abstract

Viral infections pose a significant threat to humanity, as exemplified by the COVID-19 pandemic. To mitigate the associated damage, understanding the biological characteristics of causative viruses is essential. In this study, we report a novel method for identifying host cell molecules (including virus receptors) required for viral attachment, referred to as host cell attachment factors (HCAFs). Our approach utilizes proximity labeling (PL) technology; pseudoviruses engineered to express a PL enzyme are applied to host cells, where they bind and initiate PL. Because HCAFs are expected to localize near viral attachment sites, candidate HCAFs were specifically tagged using the PL process. The analysis of influenza HCAFs enabled the identification of multiple candidate molecules. Subsequent viral attachment experiments using Chinese hamster ovary cells suggested that neuropilin-1 may serve as an HCAF for influenza viruses. Given its simplicity and rapid turnaround, this method is adaptable to a wide range of enveloped viruses, including pandemic viruses that require emergency analyses.IMPORTANCEIdentifying cellular receptors for viruses is not only crucial in conventional virology research but also plays a key role in addressing pandemic viruses. The significance of our work lies in establishing a standardized method for viral receptor identification, an area in which no widely accepted protocol has previously existed, by utilizing pseudovirus-mediated proximity labeling technology. Moreover, this approach provides a highly versatile platform that enables rapid and low-cost identification of viral receptors.

Indexed as

Membrane ProteinsReceptors, VirusSARS-CoV-2Virus AttachmentAnimalsCHO CellsCOVID-19CricetinaeCricetulusHumansStaining and LabelingMembrane ProteinsReceptors, Virusinfluenza virusmembrane proteinproximity labelingpseudovirusSARS-CoV-2virus attachment

Identifiers

PMID42053295
PMCPMC13185619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.